Table 1.

Baseline characteristics of patients.

Characteristics		n (%)
Age (year)
	Median (range), years	55(31-72)
Gender
	Male	17(51.5)
	Female	16(48.5)
Primary Diagnose
	GCB	13(39.4)
	Non-GCB	20(60.6)
Stage
	I/II	6(18.2)
	III/IV	27(81.8)
Status before leukapheresis
	PR	11(33.3)
	SD	1(3)
	PD	21(63.7)
Prior lines of therapy before leukapheresis
	1	2(6.1)
	2	11(33.3)
	3	13(39.4)
	4	4(12.1)
	>4	3(9.1)
Refractory/relapse
	Refractory	26(78.8)
	Relapsed	7(21.2)

GCB for germinal center B cell; PR or partial response; SD for steady disease; PD for progression disease.